Optum Ventures, the investment arm of UnitedHealth Group’s Optum, led a recent $26 million funding round for smartphone-based chronic condition management startup Kaia Health. Kaia Health will use the funding to continue growing its digital therapy solutions for people managing musculoskeletal conditions as well as expand therapies for new conditions such as chronic obstructive pulmonary disease. The company will continue to invest in clinical research and expand its team to grow partnerships with employers and health plans.
Kaia Health’s smartphone-based platform combines machine learning and the expertise of medical experts to create individualized treatments, including exercises, education, and psychological interventions for patients. Since launching in 2016, Kaia Health has enrolled more than 400,000 users and raised $50 million.
Optum Ventures seeks out exceptional teams with data-driven technologies and services that are poised to deeply disrupt the status quo. By investing in early-stage companies with a transformative vision for making health care better for everyone, their goal is to impact change.
Kaia offers digital programs to help people with chronic back pain and chronic obstructive pulmonary disease. Their platform has expanded to increasingly support large populations of chronic pain individuals and also those seeking a proactive routine to maintain health and wellness.
This was reported by Becker’s ASC Review on June 21, 2020.
Contact information: Optum Ventures, 75 State Street, Boston, MA 02109; Email: hello@optumventures.com; Website: www.optumventures.com
Contact information: Kaia Health, 134 N 4th St, Brooklyn, NY 11249; Email: info@kaiahealth.com; Website: www.kaiahealth.com
